• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠-葡萄糖协同转运蛋白1抑制剂的结构机制。

Structural mechanism of SGLT1 inhibitors.

作者信息

Niu Yange, Cui Wenhao, Liu Rui, Wang Sanshan, Ke Han, Lei Xiaoguang, Chen Lei

机构信息

State Key Laboratory of Membrane Biology, College of Future Technology, Institute of Molecular Medicine, Peking University, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Beijing, China.

National Biomedical Imaging Center, Peking University, Beijing, China.

出版信息

Nat Commun. 2022 Oct 28;13(1):6440. doi: 10.1038/s41467-022-33421-7.

DOI:10.1038/s41467-022-33421-7
PMID:36307403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9616851/
Abstract

Sodium glucose co-transporters (SGLT) harness the electrochemical gradient of sodium to drive the uphill transport of glucose across the plasma membrane. Human SGLT1 (hSGLT1) plays a key role in sugar uptake from food and its inhibitors show promise in the treatment of several diseases. However, the inhibition mechanism for hSGLT1 remains elusive. Here, we present the cryo-EM structure of the hSGLT1-MAP17 hetero-dimeric complex in the presence of the high-affinity inhibitor LX2761. LX2761 locks the transporter in an outward-open conformation by wedging inside the substrate-binding site and the extracellular vestibule of hSGLT1. LX2761 blocks the putative water permeation pathway of hSGLT1. The structure also uncovers the conformational changes of hSGLT1 during transitions from outward-open to inward-open states.

摘要

钠葡萄糖共转运蛋白(SGLT)利用钠的电化学梯度驱动葡萄糖逆浓度梯度穿过质膜进行转运。人类SGLT1(hSGLT1)在从食物中摄取糖分过程中起关键作用,其抑制剂在多种疾病治疗中显示出前景。然而,hSGLT1的抑制机制仍不清楚。在此,我们展示了在高亲和力抑制剂LX2761存在下hSGLT1-MAP17异二聚体复合物的冷冻电镜结构。LX2761通过楔入hSGLT1的底物结合位点和细胞外前庭,将转运蛋白锁定在向外开放的构象。LX2761阻断了hSGLT1假定的水渗透途径。该结构还揭示了hSGLT1从向外开放状态转变为向内开放状态期间的构象变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/dcbb0bbb2809/41467_2022_33421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/0423ca069364/41467_2022_33421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/3b2184164b1a/41467_2022_33421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/dcc781af0406/41467_2022_33421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/6f7fa551b85e/41467_2022_33421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/d70957bd4254/41467_2022_33421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/dcbb0bbb2809/41467_2022_33421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/0423ca069364/41467_2022_33421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/3b2184164b1a/41467_2022_33421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/dcc781af0406/41467_2022_33421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/6f7fa551b85e/41467_2022_33421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/d70957bd4254/41467_2022_33421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb22/9616851/dcbb0bbb2809/41467_2022_33421_Fig6_HTML.jpg

相似文献

1
Structural mechanism of SGLT1 inhibitors.钠-葡萄糖协同转运蛋白1抑制剂的结构机制。
Nat Commun. 2022 Oct 28;13(1):6440. doi: 10.1038/s41467-022-33421-7.
2
Structural selectivity of human SGLT inhibitors.人源 SGLT 抑制剂的结构选择性。
Am J Physiol Cell Physiol. 2012 Jan 15;302(2):C373-82. doi: 10.1152/ajpcell.00328.2011. Epub 2011 Sep 21.
3
Sodium-independent low-affinity D-glucose transport by human sodium/D-glucose cotransporter 1: critical role of tryptophan 561.人钠/葡萄糖共转运蛋白1介导的不依赖钠的低亲和力D-葡萄糖转运:色氨酸561的关键作用
Biochemistry. 2007 Mar 13;46(10):2758-66. doi: 10.1021/bi061696x. Epub 2007 Feb 9.
4
Bridging the gap between structure and kinetics of human SGLT1.弥合人 SGLT1 的结构与动力学之间的差距。
Am J Physiol Cell Physiol. 2012 May 1;302(9):C1293-305. doi: 10.1152/ajpcell.00397.2011. Epub 2011 Dec 7.
5
Discovery of LX2761, a Sodium-Dependent Glucose Cotransporter 1 (SGLT1) Inhibitor Restricted to the Intestinal Lumen, for the Treatment of Diabetes.发现 LX2761,一种仅限于肠道腔的钠依赖性葡萄糖共转运蛋白 1(SGLT1)抑制剂,用于治疗糖尿病。
J Med Chem. 2017 Jan 26;60(2):710-721. doi: 10.1021/acs.jmedchem.6b01541. Epub 2017 Jan 17.
6
Structures of human SGLT in the occluded state reveal conformational changes during sugar transport.人源 SGLT 处于掩蔽状态的结构揭示了糖转运过程中的构象变化。
Nat Commun. 2023 May 22;14(1):2920. doi: 10.1038/s41467-023-38720-1.
7
Active site voltage clamp fluorometry of the sodium glucose cotransporter hSGLT1.主动位点电压钳荧光光度法检测钠-葡萄糖协同转运蛋白 hSGLT1。
Proc Natl Acad Sci U S A. 2017 Nov 14;114(46):E9980-E9988. doi: 10.1073/pnas.1713899114. Epub 2017 Oct 30.
8
High-yield functional expression of human sodium/d-glucose cotransporter1 in Pichia pastoris and characterization of ligand-induced conformational changes as studied by tryptophan fluorescence.人钠/ D -葡萄糖共转运蛋白1在毕赤酵母中的高效功能表达及通过色氨酸荧光研究配体诱导的构象变化
Biochemistry. 2005 Nov 29;44(47):15514-24. doi: 10.1021/bi051377q.
9
Conformational dynamics of hSGLT1 during Na+/glucose cotransport.钠/葡萄糖共转运过程中hSGLT1的构象动力学
J Gen Physiol. 2006 Dec;128(6):701-20. doi: 10.1085/jgp.200609643.
10
Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes.硫代糖苷作为人钠-葡萄糖协同转运蛋白1(hSGLT1)和人钠-葡萄糖协同转运蛋白2(hSGLT2)的抑制剂:控制糖尿病患者高血糖的潜在治疗药物。
Int J Med Sci. 2007 May 5;4(3):131-9. doi: 10.7150/ijms.4.131.

引用本文的文献

1
SGLT2 Inhibitors: From Molecular Mechanisms to Clinical Outcomes in Cardiology and Diabetology.钠-葡萄糖协同转运蛋白2抑制剂:从分子机制到心脏病学和糖尿病学的临床结局
Molecules. 2025 Jul 25;30(15):3112. doi: 10.3390/molecules30153112.
2
Mechanism of substrate recognition and release of human SGLT2.人类SGLT2的底物识别与释放机制。
Nat Commun. 2025 Aug 4;16(1):7140. doi: 10.1038/s41467-025-62421-6.
3
Pathogenesis and Therapeutic Perspectives of Tubular Injury in Diabetic Kidney Disease: An Update.糖尿病肾病肾小管损伤的发病机制与治疗前景:最新进展

本文引用的文献

1
The Protein Fusion Strategy Facilitates the Structure Determination of Small Membrane Proteins by Cryo-EM.蛋白融合策略通过 cryo-EM 促进小膜蛋白的结构测定。
Biochemistry. 2023 Jan 17;62(2):196-200. doi: 10.1021/acs.biochem.2c00319. Epub 2022 Aug 1.
2
A co-expression vector for baculovirus-mediated protein expression in mammalian cells.一种用于杆状病毒介导的哺乳动物细胞蛋白表达的共表达载体。
Biochem Biophys Res Commun. 2022 Feb 26;594:69-73. doi: 10.1016/j.bbrc.2022.01.056. Epub 2022 Jan 19.
3
Structural basis of inhibition of the human SGLT2-MAP17 glucose transporter.
Biomedicines. 2025 Jun 10;13(6):1424. doi: 10.3390/biomedicines13061424.
4
ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches.ATP结合盒转运体与溶质载体转运体:通过结构和建模方法理解其机制及药物调控
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1602. doi: 10.3390/ph17121602.
5
Correction of preferred orientation-induced distortion in cryo-electron microscopy maps.纠正低温电子显微镜图谱中优选取向诱导的扭曲。
Sci Adv. 2024 Jul 26;10(30):eadn0092. doi: 10.1126/sciadv.adn0092.
6
Sodium-glucose cotransporter 1 promotes the biofunctions of perivascular preadipocytes mediated by Akt/mTOR/p70S6K signaling pathway.钠-葡萄糖共转运蛋白 1 通过 Akt/mTOR/p70S6K 信号通路促进血管周前脂肪细胞的生物功能。
Am J Physiol Cell Physiol. 2024 Jun 1;326(6):C1611-C1624. doi: 10.1152/ajpcell.00606.2023. Epub 2024 Apr 22.
7
Transport mechanism of presynaptic high-affinity choline uptake by CHT1.CHT1 介导的突触前高亲和力胆碱摄取的转运机制。
Nat Struct Mol Biol. 2024 Apr;31(4):701-709. doi: 10.1038/s41594-024-01259-w. Epub 2024 Apr 8.
8
Membrane transporters in drug development and as determinants of precision medicine.药物开发中的膜转运体和精准医学的决定因素。
Nat Rev Drug Discov. 2024 Apr;23(4):255-280. doi: 10.1038/s41573-023-00877-1. Epub 2024 Jan 24.
9
Transport and inhibition mechanism of the human SGLT2-MAP17 glucose transporter.人源 SGLT2-MAP17 葡萄糖转运蛋白的转运与抑制机制。
Nat Struct Mol Biol. 2024 Jan;31(1):159-169. doi: 10.1038/s41594-023-01134-0. Epub 2023 Dec 6.
10
SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia.SGLT5 是 1,5-脱水葡萄糖醇的肾脏转运蛋白,而 1,5-脱水葡萄糖醇在两种罕见中性粒细胞减少症形式中扮演重要角色。
Cell Mol Life Sci. 2023 Aug 18;80(9):259. doi: 10.1007/s00018-023-04884-8.
人SGLT2-MAP17葡萄糖转运蛋白抑制作用的结构基础
Nature. 2022 Jan;601(7892):280-284. doi: 10.1038/s41586-021-04212-9. Epub 2021 Dec 8.
4
Structure and mechanism of the SGLT family of glucose transporters.SGLT 家族葡萄糖转运蛋白的结构与机制。
Nature. 2022 Jan;601(7892):274-279. doi: 10.1038/s41586-021-04211-w. Epub 2021 Dec 8.
5
Does SGLT1 Inhibition Add Benefit to SGLT2 Inhibition in Type 2 Diabetes?在2型糖尿病中,钠-葡萄糖协同转运蛋白1(SGLT1)抑制是否能为钠-葡萄糖协同转运蛋白2(SGLT2)抑制带来额外益处?
Circulation. 2021 Jul 6;144(1):4-6. doi: 10.1161/CIRCULATIONAHA.121.054442. Epub 2021 Apr 23.
6
Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates.人单羧酸转运蛋白 1 被抗癌候选药物抑制的结构基础。
Cell. 2021 Jan 21;184(2):370-383.e13. doi: 10.1016/j.cell.2020.11.043. Epub 2020 Dec 16.
7
UCSF ChimeraX: Structure visualization for researchers, educators, and developers.UCSF ChimeraX:面向研究人员、教育工作者和开发者的结构可视化工具。
Protein Sci. 2021 Jan;30(1):70-82. doi: 10.1002/pro.3943. Epub 2020 Oct 22.
8
SGLT2 and cancer.钠-葡萄糖协同转运蛋白 2(SGLT2)与癌症。
Pflugers Arch. 2020 Sep;472(9):1407-1414. doi: 10.1007/s00424-020-02448-4. Epub 2020 Aug 20.
9
Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application.钠-葡萄糖共转运蛋白,SLC5 家族,以及治疗相关抑制剂:从分子发现到临床应用。
Pflugers Arch. 2020 Sep;472(9):1177-1206. doi: 10.1007/s00424-020-02433-x. Epub 2020 Aug 7.
10
Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor.人固醇 O-酰基转移酶 1 的竞争性抑制剂抑制机制的结构见解。
Nat Commun. 2020 May 18;11(1):2478. doi: 10.1038/s41467-020-16288-4.